NO20022459L - Fremgangsmåte for tidlig forutsigelse av start av invasjonskreft - Google Patents

Fremgangsmåte for tidlig forutsigelse av start av invasjonskreft

Info

Publication number
NO20022459L
NO20022459L NO20022459A NO20022459A NO20022459L NO 20022459 L NO20022459 L NO 20022459L NO 20022459 A NO20022459 A NO 20022459A NO 20022459 A NO20022459 A NO 20022459A NO 20022459 L NO20022459 L NO 20022459L
Authority
NO
Norway
Prior art keywords
invasion
cancer
procedure
early prediction
prediction
Prior art date
Application number
NO20022459A
Other languages
English (en)
Other versions
NO20022459D0 (no
Inventor
Douglas D Burkett
Original Assignee
Zila Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zila Inc filed Critical Zila Inc
Publication of NO20022459D0 publication Critical patent/NO20022459D0/no
Publication of NO20022459L publication Critical patent/NO20022459L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20022459A 2000-09-26 2002-05-24 Fremgangsmåte for tidlig forutsigelse av start av invasjonskreft NO20022459L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/026551 WO2002026266A1 (en) 2000-09-26 2000-09-26 Method for early prediction of the onset of invasive cancer

Publications (2)

Publication Number Publication Date
NO20022459D0 NO20022459D0 (no) 2002-05-24
NO20022459L true NO20022459L (no) 2002-07-05

Family

ID=21741811

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022459A NO20022459L (no) 2000-09-26 2002-05-24 Fremgangsmåte for tidlig forutsigelse av start av invasjonskreft

Country Status (12)

Country Link
US (1) US7659057B2 (no)
EP (1) EP1322339A4 (no)
JP (1) JP2004509637A (no)
CN (1) CN1399563A (no)
AU (1) AU776256B2 (no)
BR (1) BR0015706A (no)
CA (1) CA2392213A1 (no)
IL (1) IL149330A0 (no)
MX (1) MXPA02004428A (no)
NO (1) NO20022459L (no)
TW (1) TWI280366B (no)
WO (1) WO2002026266A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2000237154A1 (en) * 2000-02-28 2001-09-12 Zila, Inc. Method for detecting and killing epithelial cancer cells
US6967015B1 (en) * 2000-07-20 2005-11-22 Zila, Inc. Diagnostic method for detecting dysplastic epithelial tissue
EP1322339A4 (en) 2000-09-26 2004-05-26 Zila Inc METHOD FOR EARLY Predicting the Occurrence of INVASIVE CANCER.
MXPA04002659A (es) * 2001-12-14 2004-06-18 Zila Inc Analisis molecular dirigido por tincion para pronostico y diagnostico de cancer.
BRPI0419122A (pt) * 2004-09-30 2007-12-11 Zila Biotechnology Inc método direcionado por luz para detectar e ajudar uma avaliação adicional de tecido mucoso anormal
US20080044351A1 (en) * 2006-08-15 2008-02-21 Xin Ye Method and procedure to detect oral tissues with high-risk molecular profiles
US20090023138A1 (en) * 2007-07-17 2009-01-22 Zila Biotechnology, Inc. Oral cancer markers and their detection

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4321251A (en) * 1979-12-19 1982-03-23 The United States Of America As Represented By The Department Of Health And Human Services Detection of malignant lesions of the oral cavity utilizing toluidine blue rinse
WO1993008847A1 (en) * 1991-10-31 1993-05-13 Ctm Associates, Inc. Biological stain composition, method of preparation and method of use for delineation of epitheleal cancer
US6417003B1 (en) * 1993-01-14 2002-07-09 Zila, Inc. Method and kit for epithelial cancer screening
CA2156920A1 (en) 1993-02-24 1994-09-01 Stephen N. Thibodeau Tumor-specific genomic instability as a prognostic indicator
US5786227A (en) * 1995-06-07 1998-07-28 Biex, Inc. Fluid collection kit and method
NZ322108A (en) 1995-11-13 1999-11-29 Provalis Uk Ltd Diagnostic test apparatus
KR100342342B1 (ko) * 1996-01-16 2002-08-22 자일러, 인코포레이티드 구강암및전암성질환의체내검출을위한방법및조성물
US6194573B1 (en) * 1997-11-13 2001-02-27 Zila, Inc. Process for manufacture of in vivo stain composition
US6086852A (en) * 1997-11-13 2000-07-11 Zila, Inc. In vivo stain composition, process of manufacture, and methods of use to identify dysplastic tissue
US6241683B1 (en) * 1998-02-20 2001-06-05 INSTITUT DE RECHERCHES CLINIQUES DE MONTRéAL (IRCM) Phonospirometry for non-invasive monitoring of respiration
US6405070B1 (en) * 1998-06-16 2002-06-11 Bhaskar Banerjee Detection of cancer using cellular autofluorescence
US6256530B1 (en) * 1998-09-15 2001-07-03 Denvu, L.L.C. Optical instrument and technique for cancer diagnosis using in-vivo fluorescence emission of test tissue
US6649144B1 (en) * 2000-02-28 2003-11-18 Zila, Inc. Method for detecting and killing epithelial cancer cells
AU2000237154A1 (en) * 2000-02-28 2001-09-12 Zila, Inc. Method for detecting and killing epithelial cancer cells
US6376525B1 (en) * 2000-09-15 2002-04-23 Qingzhong Kong Method and composition for treating cancer using cellular organelle crystallizing agents
EP1322339A4 (en) 2000-09-26 2004-05-26 Zila Inc METHOD FOR EARLY Predicting the Occurrence of INVASIVE CANCER.
MXPA04002659A (es) 2001-12-14 2004-06-18 Zila Inc Analisis molecular dirigido por tincion para pronostico y diagnostico de cancer.

Also Published As

Publication number Publication date
IL149330A0 (en) 2002-11-10
EP1322339A1 (en) 2003-07-02
CN1399563A (zh) 2003-02-26
US7659057B2 (en) 2010-02-09
AU7987100A (en) 2002-04-08
TWI280366B (en) 2007-05-01
AU776256B2 (en) 2004-09-02
WO2002026266A1 (en) 2002-04-04
EP1322339A4 (en) 2004-05-26
CA2392213A1 (en) 2002-04-04
BR0015706A (pt) 2002-07-16
NO20022459D0 (no) 2002-05-24
US20040235067A1 (en) 2004-11-25
MXPA02004428A (es) 2002-09-02
JP2004509637A (ja) 2004-04-02

Similar Documents

Publication Publication Date Title
CY2020005I1 (el) Παραγωγο ραπαμυκινης για τη θεραπευτικη αντιμετωπιση καρκινου του παγκρεατος
EA200000274A3 (ru) Способы получения и промежуточные соединения для получения противораковых соединений
AR028567A1 (es) Nuevos derivados de fenil-propargileter
NO20035426L (no) Fremgangsmate ved administrering av anti-TNF-D-antistoff
EE200200673A (et) Kinasoliini derivaadid kasvajate raviks
AR028596A1 (es) Nuevos derivados de fenilglicina
NO20033203D0 (no) Terapeutiske heterocykliske forbindelser
NO20031443D0 (no) Forbindelser nyttige for behandling av inflammatoriske sykdommer
NO20022221D0 (no) Metode for kjemisk forhindring av prostatakreft
ID30187A (id) Dongkrak jenis pantagraf
IS6917A (is) Epóþílon afleiður til meðhöndlunar erfiðra æxla
NO20022459D0 (no) Fremgangsmåte for tidlig forutsigelse av start av invasjonskreft
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
NO20055449D0 (no) Fremgangsmate for diagnostisering av behandling av kreft
ID30100A (id) Suatu zat tambahan pakan
EE200200389A (et) Imidasooli uued derivaadid
PT1175417E (pt) Compostos substituidos de benzolactamas
PT1231206E (pt) Composicoes estabilizadas de peroxidicarbonatos organicos
NO20025789L (no) Syntesefremgangsmåte for fluormetylering av halogenerte alkoholer
FI20011908A0 (fi) Menetelmä vatsasyövän osoittamiseksi
PT1232141E (pt) Eteres de o-desmetil-venlafaxina
ID27627A (id) Proses pembuatan senyawa-senyawa eter siklik piperidinilaminometil trifluorometil
TW535516U (en) Improved structure of device for forming instep
IDP000026456A (id) Senyawa-senyawa siklopropanakarboksilat ester
SE0000713D0 (sv) Methods of synthesis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application
FC2A Withdrawal, rejection or dismissal of laid open patent application